Intero Biosystems

Miniature Human Organs for Preclinical Drug Development.

Intero Biosystems operates in health based in Sugar Land, Texas.

Profile

Intero Biosystems is a pioneering health company specializing in the development of miniature organs for preclinical testing. Addressing the high failure rate of drugs in clinical trials, Intero Biosystems has created the first stem cell-derived human "mini gut" that replicates the cell types, spatial structure, and function of the human intestine. Their flagship product, GastroScreen, features the intestinal lining, functional smooth muscle for peristalsis, perfusable blood vessels, and responsive neurons—forming a complete mini-organ "in a dish." GastroScreen is a valuable tool for drug testing, disease modeling, and functional assessments of critical organ functions, enabling customers to mitigate risks and identify safer, more effective compounds before human trials. Intero Biosystems' innovative approach revolutionizes preclinical testing, offering a more accurate and reliable model for predicting human outcomes.

Within the health space, the company focuses on its core offering rather than a broad product line.

The company is recorded as being based in Sugar Land, Texas.

The company is listed at the Plug and Play portfolio startup stage of development.

Website: www.interobiosystems.com